Definitive Hypofractionated Intensity-modulated Radiation Theraphy With Concurrent Chemotherapy in Cervical Cancer

This study is testing a shorter, more intense course of radiation therapy (called hypofractionated IMRT) combined with chemotherapy as a treatment for locally advanced cervical cancer. The goal is to see if this condensed schedule is as effective as the standard approach while being more convenient for patients. **You may be eligible if...** - You have been diagnosed with cervical cancer confirmed by biopsy (squamous cell, adenocarcinoma, or adenosquamous types) - Your cancer is stage IIB through IVA (advanced but not spread outside the pelvis) - You are 20 years or older - You are in good enough health to tolerate treatment (ECOG 0–1) - Your blood counts and kidney function are within acceptable ranges **You may NOT be eligible if...** - Your cancer has spread to distant organs (metastatic) - You have had prior pelvic radiation - You have already received chemotherapy or chemoradiation for cervical cancer - You have had surgery for this cancer - You have had a cervical cone biopsy or LEEP procedure before radiation - You have another active cancer (except minor skin cancers or early bladder cancer) Talk to your doctor to see if this trial is right for you.